Mirion Technologies reported Q2 2026 results that reinforce its position as a global leader in radiation safety products and services across nuclear and medical sectors. The company's durable moat arises from deep penetration in nuclear power plants and cancer centers worldwide, supported by high technical complexity and regulatory compliance. Recent acquisitions further expand its product suite, particularly in nuclear energy markets, while ongoing geopolitical tensions pose supply chain and cost risks. Growth prospects center on Small Modular Reactors, digital radiation monitoring platforms, and expanding recurring service contracts.